Clinical use of EpiSign proven for diagnosing rare heritable disorders
LONDON, ON – A study led by researchers at Lawson Health Research Institute (Lawson) provides clinical validation of EpiSign, a molecular genomics test that diagnoses rare, heritable neurodevelopmental conditions. Invented at Lawson by Dr. Bekim Sadikovic, the diagnostic test uses machine learning...